Finance
Food group Danone to step up acquisitions after strong 2024 cash performance
Published by Global Banking & Finance Review®
Posted on February 26, 2025
3 min readLast updated: January 25, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on February 26, 2025
3 min readLast updated: January 25, 2026
Danone plans acquisitions in health and medical nutrition after a strong 2024 cash performance, exceeding sales expectations.
By Dominique Vidalon
PARIS (Reuters) -French food group Danone said on Wednesday it would use some of its record cash for acquisitions as it further expands into health and medical nutrition, having delivered 2024 sales slightly above analysts' expectations.
The consumer goods giant, whose brands include Evian and Badoit water and Activia yoghurt, also improved its profit margin last year thanks to higher volumes as price hikes slowed.
"Danone is now stronger, more resilient. The company is ready for more challenges," CEO Antoine de Saint-Affrique said.
When asked how Danone would use some of the 3 billion euros ($3.15 billion) in cash it said it generated last year, Saint-Affrique told analysts: "We want to move to the front foot on acquisitions."
Saint-Affrique cited specialized nutrition and products where "science can make a difference" for consumers as targets.
Danone reported 2024 sales of 27.376 billion euros, a like-for-like rise of 4.3%, compared with analysts' expectations of 4.2% in a company-provided consensus.
The performance reflected sustained demand for medical nutrition and baby food in China as well as coffee creamers and high protein products in North America.
The recurring operating margin for 2024 rose to 13% of sales from 12.6% in 2023, in line with expectations of 13%.
For 2025, Danone said its forecast was in line with its mid-term ambition of like-for-like sales growth of 3% to 5%, with recurring operating income growing faster than sales.
Saint-Affrique declined to provide analysts with forecasts for the first quarter, saying Danone does not give quarterly guidance.
Its shares were up by 0.8% in early morning trade.
"Share price could see a limited outperformance to peers on the headline sales beat but after a strong year to date performance, we see nothing new here to support further rerate," Jefferies analysts said in a note, citing "an uninspiring outlook for now."
With record cash flow of 3 billion euros in 2024, which came above analysts' expectations of 2.45 billion, Danone also plans to raise its dividend by 2.4% to 2.15 euros per share.
'VOLATILE WORLD'
Danone, like rivals Unilever and Nestle, has slowed price hikes after three years of steep increases following the COVID-19 pandemic to win back shoppers who had turned to cheaper brands during a surge in inflation.
"We foresee for 2025 what I would call an almost back to normal level of inflation, remaining within a reasonable corridor," Chief Financial Officer Juergen Esser said.
"From what we know today this inflation will be driven mainly by milk, milk ingredients, and few components of packaging," he said.
Esser noted though some price swings were possible.
"We are living in a volatile world, and so there could be some ups and downs ... which could come from energy, ups and downs which could come from potential custom duties."
For the fourth quarter alone, sales grew 4.7%, beating analysts' estimates of 4.2%, with contributions from all its three businesses - Essential Dairy products (EDP), Specialised Nutrition and Waters.
($1 = 0.9531 euros)
($1 = 0.9527 euros)
(Reporting by Dominique Vidalon; Additional reporting by Diana Mandia; Editing by Sudip Kar-Gupta, Ingrid Melander and Tomasz Janowski)
The article discusses Danone's plan to increase acquisitions following a strong cash performance in 2024.
Danone reported sales slightly above expectations and a recurring operating margin increase to 13%.
Danone aims to expand into health and medical nutrition, focusing on acquisitions.
Explore more articles in the Finance category
